Amneal Pharmaceuticals has just seen its fair value estimate nudged to US$14.00 from US$13.80, a small but meaningful reset that ties directly to how the latest quarterly numbers stack up against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback